Healthcare


 Orthocell Expands Remplir™ Reach into Hong Kong, Strengthening Global Presence Among ASX200 Growth Stories

Orthocell Expands Remplir™ Reach into Hong Kong, Strengthening Global Presence Among ASX200 Growth Stories

May 13, 2025 11:59 AM AEST| By Team Kalkine Media

Highlights,Orthocell,gains fast-track regulatory approval in Hong Kong,Expands global footprint for,Remplir,™ nerve repair product,Eyes broader S&P/ASX200 exposure with strategic regional moves,Orthocell Ltd (ASX:OCC) has achieved another milestone i...

 Tryptamine Therapeutics Appoints New Chairman to Drive Clinical Growth in Psychedelic Therapy

Tryptamine Therapeutics Appoints New Chairman to Drive Clinical Growth in Psychedelic Therapy

May 12, 2025 04:24 PM AEST| By Team Kalkine Media

Highlights:,Herwig Janssen appointed as new non-executive chairman of Tryptamine Therapeutics Ltd.,The company advances toward clinical trials using TRP-8803 to treat binge eating disorder.,Strengthened board with Chris Ntoumenopoulos transitioning t...

 Bio-Gene Technology Launches Share Plan Amid Strategic Growth Focus in ASX200 Landscape

Bio-Gene Technology Launches Share Plan Amid Strategic Growth Focus in ASX200 Landscape

May 12, 2025 02:58 PM AEST| By Team Kalkine Media

Highlights,Bio-Gene (BGT) opens Share Purchase Plan post $2.1M raise,Eligible shareholders offered shares at $0.023 with bonus options,Proceeds to support Flavocide®, Qcide® and regulatory initiatives,Bio-Gene Technology Limited (ASX:BGT), an Austral...

 Can ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?

Can ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?

May 11, 2025 04:30 PM AEST| By Team Kalkine Media

Can ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?

 Is Lumos Diagnostics Limited Positioned for Growth Amid Valuation Concerns in the S&P/ASX 200 Index?

Is Lumos Diagnostics Limited Positioned for Growth Amid Valuation Concerns in the S&P/ASX 200 Index?

May 10, 2025 10:34 AM AEST| By Team Kalkine Media

Is Lumos Diagnostics Limited Positioned for Growth Amid Valuation Concerns in the S&P/ASX 200 Index?

 Could Micro-X's Capital Activity Reflect Broader ASX Emerging Company Trends?

Could Micro-X's Capital Activity Reflect Broader ASX Emerging Company Trends?

May 10, 2025 10:32 AM AEST| By Team Kalkine Media

Could Micro-X's Capital Activity Reflect Broader ASX Emerging Company Trends?

 Is This Healthcare Stock on the ASX 50 and ASX 200 Reflecting Broader Sector Moves?

Is This Healthcare Stock on the ASX 50 and ASX 200 Reflecting Broader Sector Moves?

May 09, 2025 04:38 PM AEST| By Team Kalkine Media

Is This Healthcare Stock on the ASX 50 and ASX 200 Reflecting Broader Sector Moves?

 Healius Ltd (ASX: HLS) Experiences Significant Decline as Shares Go Ex-Dividend

Healius Ltd (ASX: HLS) Experiences Significant Decline as Shares Go Ex-Dividend

May 09, 2025 04:02 PM AEST| By Team Kalkine Media

Highlights:,Healius Ltd (ASX:HLS) shares drop sharply after going ex-dividend.,A special dividend following the sale of Lumus Imaging contributes to the decline.,Shareholders are set to receive a substantial fully franked dividend in the near future....

 Orthocell (ASX:OCC) Expands US Rollout of Remplir, Outpaces Distribution Goals | ASX 200 Health Sector Update

Orthocell (ASX:OCC) Expands US Rollout of Remplir, Outpaces Distribution Goals | ASX 200 Health Sector Update

May 09, 2025 02:05 PM AEST| By Team Kalkine Media

Highlights,Orthocell (ASX:OCC) secures distributor coverage across multiple US states for Remplir,Pre-launch groundwork includes medical education and hospital engagement strategies,Company preparing for further regulatory steps in Europe and the UK,...

 Avita Medical’s Q1 Revenue Surge Overshadowed by ASX200 Market Reaction

Avita Medical’s Q1 Revenue Surge Overshadowed by ASX200 Market Reaction

May 09, 2025 12:04 PM AEST| By Team Kalkine Media

Highlights,Avita Medical reports 67% rise in Q1 revenue,Net loss narrows, but share price sees steep dip,Company,maintains,full-year growth and cash flow outlook,Avita Medical (ASX:AVH), a biotech firm dual-listed on the ASX and NASDAQ, reported a si...

 Avita Medical’s Revenue Surge Highlights Momentum in ASX200 Healthcare Sector

Avita Medical’s Revenue Surge Highlights Momentum in ASX200 Healthcare Sector

May 09, 2025 10:46 AM AEST| By Team Kalkine Media

Highlights,Avita Medical delivers 67% YoY revenue growth,Full-year outlook,remains,strong with up to 65% revenue increase,Customer base expansion drives top-line performance,Avita Medical (ASX:AVH) has posted a robust revenue performance for the rece...

 Is RoXsta by Memphasys Transforming Antioxidant Diagnostics in the ASX Healthcare Sector?

Is RoXsta by Memphasys Transforming Antioxidant Diagnostics in the ASX Healthcare Sector?

May 08, 2025 05:43 PM AEST| By Team Kalkine Media

Is RoXsta by Memphasys Transforming Antioxidant Diagnostics in the ASX Healthcare Sector?

 Medical Developments International Limited: Price Action and Future Growth Outlook (ASX 200)

Medical Developments International Limited: Price Action and Future Growth Outlook (ASX 200)

May 08, 2025 05:01 PM AEST| By Team Kalkine Media

Highlights:,Medical Developments International Limited has recently experienced a significant rebound in share price.,Despite the rise, the company’s price-to-sales ratio is notably low compared to others in the pharmaceuticals sector.,Revenue growth...

 Cochlear Limited: A Look at the ASX 200 Stock's Fundamentals Amid Recent Price Decline

Cochlear Limited: A Look at the ASX 200 Stock's Fundamentals Amid Recent Price Decline

May 08, 2025 04:34 PM AEST| By Team Kalkine Media

Highlights:,Cochlear Limited (ASX:COH) has faced a decline in share price in recent months.,Despite the decline, the company maintains solid fundamentals and strong return on equity (ROE).,Earnings growth has been impressive when compared to the indu...

 Is Nova Eye’s ASX Listing Reflecting Its Medical Sector Revenue Trends?

Is Nova Eye’s ASX Listing Reflecting Its Medical Sector Revenue Trends?

May 08, 2025 02:35 PM AEST| By Team Kalkine Media

Is Nova Eye’s ASX Listing Reflecting Its Medical Sector Revenue Trends?

 Is PainChek Showing Financial Progress in the ASX Emerging Companies Index?

Is PainChek Showing Financial Progress in the ASX Emerging Companies Index?

May 08, 2025 02:33 PM AEST| By Team Kalkine Media

Is PainChek Showing Financial Progress in the ASX Emerging Companies Index?

 How Is Nyrada Inc. Performing in the ASX Health Sector?

How Is Nyrada Inc. Performing in the ASX Health Sector?

May 08, 2025 02:32 PM AEST| By Team Kalkine Media

How Is Nyrada Inc. Performing in the ASX Health Sector?

 Memphasys’ RoXsta Diagnostic Technology Gains Traction Amid ASX200 Innovation Surge

Memphasys’ RoXsta Diagnostic Technology Gains Traction Amid ASX200 Innovation Surge

May 08, 2025 02:03 PM AEST| By Team Kalkine Media

Highlights,Memphasys pilot validates RoXsta’s rapid diagnostic capabilities,RoXsta processes 96 samples in under an hour,Potential applications span human fertility and veterinary science,Memphasys (ASX:MEM) has reported a successful pilot study of i...

 Pro Medicus Expands in US Healthcare Market with $20M Imaging Deal, Strengthening S&P/ASX200 Presence

Pro Medicus Expands in US Healthcare Market with $20M Imaging Deal, Strengthening S&P/ASX200 Presence

May 08, 2025 01:50 PM AEST| By Team Kalkine Media

Highlights,Pro Medicus lands a major $20 million imaging deal,University of Iowa's M&A strategy could drive further PME growth,PME gains visibility within the ASX200 healthcare segment,Australian medical imaging technology company Pro Medicus (ASX:PM...

 ASX200 Spotlight: ResMed (ASX:RMD) Sees Growing Interest in Healthcare Innovation

ASX200 Spotlight: ResMed (ASX:RMD) Sees Growing Interest in Healthcare Innovation

May 08, 2025 01:07 PM AEST| By Team Kalkine Media

Highlights,ResMed (RMD) shares show resilience with 2025 gains,Key healthcare themes driving long-term global growth,Ethical focus and tech-driven strategy position RMD as a standout,As 2025 unfolds, ResMed (ASX:RMD), a global medical technology comp...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.